Rafael Nadal once again won the French Open gravel, but the 36-year-old Spaniard is still a headache. He could only tolerate the pain in his left leg by injection. “I can’t and I don’t want to keep playing that way.”

In his acceptance speech at Court Philippe-Chatrie after his 14th victory at the French Open, Rafael Nadal promised to fight to extend his career. But the pain in his left leg causes him more than just a headache.

The Spaniard suffers from Mullerweiss’s disease on his left foot, a rare and complex foot defect. He wants a pain solution. “As I said earlier, I can’t continue playing and I don’t want to continue,” he said at a press conference.

Before every match in Paris, Nadaru received an injection to control his leg pain. “I was only able to play here thanks to those injections. The injections suppressed the nerves in my left foot.”

“I played painlessly, but I didn’t feel any sensations in my feet. It’s like anesthetizing a dentist. I could only play this way. It might be a one-time solution. Maybe, but not long-a long-term solution. “

Wimbledon is not the tournament you want to miss. But I only join Wimbledon when I’m ready.

Now Nadaru is in the fight against time to reach Wimbledon. “Wimbledon is not a tournament you want to miss,” said the Spaniards who won Wimbledon in 2008 and 2010. “But I only join Wimbledon when I’m ready.”

“Wimbledon is always a priority for me, so I’ll do it if I can play with anti-inflammatory drugs, but if I have to give an injection before every match … I don’t want to put myself in that position.” Wimbledon will start on June 27th.

Next week, Nadaru will start a new treatment to permanently control foot pain. “If it works, I will continue. If it doesn’t work, it will be another story.”

Another story may be dangerous surgery. “There is no guarantee that my career will continue at the highest level and there is a risk that I will have to recover for a long time. I have completed all my careers so far and I would like to go step by step.”

Source: Sporza

LEAVE A REPLY

Please enter your comment!
Please enter your name here